首页> 外文期刊>The Journal of Allergy and Clinical Immunology >Constitutive expression of endothelin in bronchial epithelial cells of patients with symptomatic and asymptomatic asthma and modulation by histamine and interleukin-1.
【24h】

Constitutive expression of endothelin in bronchial epithelial cells of patients with symptomatic and asymptomatic asthma and modulation by histamine and interleukin-1.

机译:有症状和无症状哮喘患者支气管上皮细胞中内皮素的组成型表达以及组胺和白介素-1的调节。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: An upregulation of endothelin-1 expression occurs in bronchial epithelial cells of asthmatic patients. This peptide may mediate bronchoconstriction in asthma, but the mechanisms that modulate endothelin-I synthesis and release are unknown. OBJECTIVE: This study was done to compare the pattern of endothelin-1 expression in patients with symptomatic and asymptomatic asthma and evaluate the ability of inflammatory factors to upregulate endothelin-1 synthesis and release in the epithelial cells of subjects who are free of symptoms. METHODS: Two groups of 10 asthmatic patients were selected. One group had symptomatic asthma with airflow obstruction and moderately to severely increased airway responsiveness. The second group was free of symptoms: they did not show airflow obstruction, and airway responsiveness was borderline or slightly increased. Bronchial biopsy specimens were obtained by means of bronchoscopy and used for immunohistochemical evaluation, epithelial cell isolation, and stimulation experiments with interleukin-1 and histamine. RESULTS: Endothelin-1 immunoreactivity was detected in vivo in the bronchial epithelial cells of all the patients with symptoms and in only two subjects without current symptoms. Incubation of bronchial epithelial cells from patients with asymptomatic asthma with interleukin-1 or histamine, for 8 to 24 hours, resulted in increased expression of endothelin-1 messenger RNA and release of appreciable amounts of the peptide to the culture medium. Those effects were dose- and time-dependent. Histamine and interleukin-1 were effective at concentrations similar to those detected in the bronchoalveolar lavage of patients with symptomatic asthma. CONCLUSION: Endothelin-expression is upregulated in bronchial epithelial cells of asthmatic patients with symptoms and evidence of functional derangement as compared with patients without symptoms and airflow obstruction. Exposure of cells from patients with asymptomatic asthma to factors that are released during acuteexacerbation of the disease induces endothelin synthesis and release.
机译:背景:哮喘患者支气管上皮细胞中内皮素-1的表达上调。该肽可能介导哮喘中的支气管收缩,但调节内皮素I合成和释放的机制尚不清楚。目的:本研究旨在比较有症状和无症状哮喘患者内皮素-1的表达模式,并评估炎症因子上调无症状受试者上皮细胞中内皮素-1的合成和释放的能力。方法:选择10例哮喘患者的两组。一组患有症状性哮喘并伴有气流阻塞,中度至严重增加了气道反应性。第二组没有症状:他们没有表现出气流阻塞,并且气道反应性处于临界状态或略有增加。通过支气管镜检查获得支气管活检标本,并将其用于免疫组织化学评估,上皮细胞分离以及白介素-1和组胺的刺激实验。结果:在所有有症状的患者的支气管上皮细胞中和只有两个没有当前症状的受试者中,在体内检测到了内皮素-1免疫反应性。将无症状性哮喘患者的白细胞介素-1或组胺与支气管上皮细胞一起孵育8至24小时,可导致内皮素1信使RNA的表达增加,并向培养基中释放出可观量的多肽。这些影响是剂量和时间依赖性的。组胺和白介素-1在类似于症状性哮喘患者的支气管肺泡灌洗中所检测到的浓度下有效。结论:与没有症状和气流阻塞的患者相比,有症状和功能紊乱的哮喘患者支气管上皮细胞中内皮素的表达上调。将无症状哮喘患者的细胞暴露于疾病急性加重期间释放的因子会诱导内皮素合成和释放。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号